Comprehensive summary: Japan approved stem cell types and indications, covering diabetes, arthritis, anti-aging and other fields

In December, Japan approved stem cells for the clinical treatment of Parkinson's disease, and the inspiration for China's stem cell therapy!

First proof! RNAa leading strong entry, hematopoietic stem cell gene therapy ushered in new opportunities for development

Several policies and measures to promote the high-quality development of biomedicine industry in Guangzhou

Stem cells are in the sky again! The successful launch of the spacecraft may solve the problem of osteoporosis!

Stem cells：break through the bottleneck of treatment of many diseases, recreate health, and provide infinite possibilities for life remodeling

CDE issued the Technical Guidelines for Clinical Trials of Gene Therapy Products for Rare Diseases, which will take effect from the date of publication

CDE issued the "Technical Guidelines for Clinical Trials of Mesenchymal Stem Cells for Prevention and Treatment of graft-versus-host Disease", which will be implemented as of the date of publication